Choosing Treatments on the Basis of Cost: Can Clinicians Opt for Less Expensive Treatments?
Author:
Affiliation:
1. Center for Drug Policy, Partners Healthcare, Needham; Massachusetts General Hospital; and Harvard Medical School, Boston, MA
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Health Policy,Oncology (nursing),Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2014.003152
Reference17 articles.
1. American Society of Clinical Oncology 2013 Top Five List in Oncology
2. PB Bach, LB Saltz, RE Wittes : In cancer care, cost matters New York Times A25,2012 10 14 www.nytimes.com/2012/10/15/opinion/a-hospital-says-no-to-an-11000-a-month-cancer-drug.html?_r=0
3. A Pollack : Sanofi halves price of cancer drug Zaltrap after Sloan-Kettering rejection New York Times B3,2012 11 8 www.nytimes.com/2012/11/09/business/sanofi-halves-price-of-drug-after-sloan-kettering-balks-at-paying-it.html
4. Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
5. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Default Options: Opportunities to Improve Quality and Value in Oncology;Journal of Clinical Oncology;2016-06-01
2. Choosing Wisely: Where's the Beef?;Journal of Oncology Practice;2015-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3